Mary Chapman, features writer —

The Bluefield Project to Cure FTD will receive $1.2 million from the Alzheimer’s Drug Discovery Foundation (ADDF) to validate an exploratory blood test in frontotemporal dementia (FTD). The award is the first FTD investment through the foundation’s Diagnostics Accelerator, a venture philanthropy vehicle to advance the development…

The Alzheimer’s Association and the African Methodist Episcopal Church (AME Church) announced a three-year partnership to promote greater involvement in the fight against Alzheimer’s (AD) and to heighten awareness of the support needed by patients and their families. Through the leadership of its International Health Commission, the…

The National Institutes of Health (NIH) has awarded the Alzheimer’s Association $1.34 million to find more evidence-based ways to enhance care and support for those with Alzheimer’s disease (AD) or other dementias, and their care partners. The five-year grant will support a project titled “Leveraging an Interdisciplinary Consortium…

A team led by a University of Washington (UW) School of Medicine scientist will use a $17.2 million National Institute on Aging (NIA) grant to study whether degenerative eye diseases are linked to Alzheimer’s disease (AD). The award went to Cecilia Lee, an assistant professor of ophthalmology. Along…

Expanding their existing relationship, Seniorlink and Humana are offering a program that provides additional care management and support to families caring for individuals with dementia, including Alzheimer’s disease. The dementia management program, which covers Humana Medicare Advantage members, capitalizes on Seniorlink’s experience and expertise in supporting caregivers. Specifically,…

Laying the foundation for what could be a pivotal clinical trial into Alzheimer’s (AD) detection, Optina Diagnostics and Wagner Macula & Retina Center will collaborate on a “real-world” study aimed at advancing Optina’s retinal deep phenotyping platform. “It brings together a whole new paradigm for the way we…

Efforts are underway this month to focus attention on Alzheimer’s (AD), a disease that, along with other forms of dementia, affects some 44 million people globally and is rapidly growing in prevalence. During November in the U.S., Alzheimer’s Awareness Month observances include online tributes to caregivers, listings of…

Landline-style phone service provider teleCalm will use a $100,000 award to advance its new phone service for dementia patients, which helps keep people with Alzheimer’s and related conditions safely connected with family and friends. The Diamond Award was presented by the Austin, Texas offices of MassChallenge, a…

An eminent Alzheimer’s disease (AD) scientist, Michel Goedert, and an early career genomic engineering investigator, Patrick Hsu, are inaugural winners of the Rainwater Prize Program that acknowledges leading work in brain research. Such work includes groundbreaking efforts to advance new treatments for neurodegenerative disorders, including Alzheimer’s, that are associated with…

The writing style of a woman’s diary entries over 31 years has given researchers a glimpse into the progression of her cognitive decline from Alzheimer’s disease, revealing a relationship between language use and the transition from healthy to severe dementia. University of Toronto (UT) researchers specializing in language…